Your session is about to expire
← Back to Search
Computed Tomography Perfusion Imaging for Pancreatic Cancer
N/A
Waitlist Available
Led By Ryan O'Malley
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
A diagnosis of pancreatic ductal adenocarcinoma
Signed informed consent form
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 years
Awards & highlights
Study Summary
This trial uses CT images to see how well a tumor responds to chemo/radiation, which may help guide treatment for pancreatic cancer patients.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in CT tumor perfusion parameter (Ktrans)
Change in CT tumor perfusion parameter (blood flow)
Change in CT tumor perfusion parameter (blood volume)
+5 moreSide effects data
From 2018 Phase 2 trial • 22 Patients • NCT0210191877%
Hypertension
68%
Headache
45%
Mucositis oral
41%
Hoarseness
32%
Proteinuria
27%
Fatigue
23%
Constipation
23%
Nausea
23%
Abdominal pain
23%
Vomiting
18%
Alanine aminotransferase increased
18%
Diarrhea
18%
Arthralgia
14%
Neutrophil count decreased
14%
Creatinine increased
14%
Anorexia
14%
Pain
14%
Palmar-plantar erythrodysesthesia syndrome
14%
Epistaxis
14%
Weight loss
14%
Aspartate aminotransferase increased
14%
Platelet count decreased
14%
Anemia
9%
Sinusitis
5%
Dehydration
5%
Upper gastrointestinal hemorrhage
5%
cholecystitis
5%
Hemorrhage Upper GI
5%
Pain Abdominal
100%
80%
60%
40%
20%
0%
Study treatment Arm
Aflibercept 6 mg /kg IV
Trial Design
1Treatment groups
Experimental Treatment
Group I: Diagnostic (CT perfusion sequence)Experimental Treatment1 Intervention
Patients undergo CT perfusion sequence during the first 40 seconds of the baseline standard of care CT scan and during follow-up CT scans at 2 and possibly 4 months after chemotherapy, at 4-6 weeks after radiation therapy, or prior to definitive surgery.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Computed Tomography Perfusion Imaging
2016
Completed Phase 2
~90
Find a Location
Who is running the clinical trial?
University of WashingtonLead Sponsor
1,728 Previous Clinical Trials
1,840,859 Total Patients Enrolled
Ryan O'MalleyPrincipal InvestigatorFred Hutch/University of Washington Cancer Consortium
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger